Related Experiment Videos
A new synthetic methodology for tiazofurin
1ICN Pharmaceuticals, Inc., 3300 Hyland Avenue, Costa Mesa, California 92626, USA.
Nucleosides, Nucleotides & Nucleic Acids
|September 21, 2001
Summary
A novel synthesis of tiazofurin, an important antiviral and anticancer agent, was developed. This new method utilizes a readily available ribofuranosyl cyanide derivative for efficient production.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Synthetic Chemistry
Background:
- Tiazofurin is a nucleoside analog with significant therapeutic potential.
- Efficient synthesis of tiazofurin is crucial for its further development and application.
- Existing synthetic routes may have limitations in yield or accessibility of starting materials.
Purpose of the Study:
- To describe a new and improved synthetic pathway for tiazofurin.
- To establish a reliable method for producing tiazofurin from accessible precursors.
Main Methods:
- The synthesis starts with 2,3-O-isopropylidene-5-O-benzoyl-beta-D-ribofuranosyl cyanide.
- A novel reaction sequence is employed to convert the starting material into tiazofurin.
Main Results:
- A new synthesis of tiazofurin has been successfully achieved.
- The described method provides a viable route to tiazofurin.
Conclusions:
- The developed synthetic strategy offers a practical approach to tiazofurin.
- This synthesis contributes to the availability of tiazofurin for research and potential therapeutic use.